Eugene Goufman

1.1k total citations
21 papers, 878 citations indexed

About

Eugene Goufman is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eugene Goufman has authored 21 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Eugene Goufman's work include Cancer-related Molecular Pathways (7 papers), Protease and Inhibitor Mechanisms (5 papers) and Cancer Research and Treatments (3 papers). Eugene Goufman is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Protease and Inhibitor Mechanisms (5 papers) and Cancer Research and Treatments (3 papers). Eugene Goufman collaborates with scholars based in Russia, United States and Tajikistan. Eugene Goufman's co-authors include Andrei L. Gartel, Angela L. Tyner, Feridoon Najmabadi, Xin Ye, Nissim Hay, Michael S. Serfas, Sergei A. Moshkovskii, Olga V. Tikhonova, Marina V. Serebryakova and Alexander I. Archakov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Experimental Cell Research.

In The Last Decade

Eugene Goufman

17 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Goufman Russia 10 695 353 129 96 69 21 878
Kirsten H. Edmiston United States 13 545 0.8× 185 0.5× 148 1.1× 142 1.5× 43 0.6× 21 798
Krista Meyer United States 10 582 0.8× 250 0.7× 76 0.6× 54 0.6× 63 0.9× 20 808
Vera Timmermans‐Wielenga Denmark 16 286 0.4× 221 0.6× 195 1.5× 95 1.0× 51 0.7× 21 624
Yutaka Hoshikawa Japan 14 868 1.2× 182 0.5× 136 1.1× 155 1.6× 95 1.4× 18 1.2k
Christine Sansome United States 6 507 0.7× 419 1.2× 93 0.7× 59 0.6× 39 0.6× 6 664
Simone W. Span Netherlands 15 1.1k 1.6× 410 1.2× 176 1.4× 53 0.6× 177 2.6× 17 1.3k
Katja Parapatics Austria 14 762 1.1× 195 0.6× 86 0.7× 33 0.3× 58 0.8× 18 962
Kristina B. Emdal Denmark 13 469 0.7× 127 0.4× 99 0.8× 85 0.9× 65 0.9× 15 606
Yi Hua Qiu United States 18 974 1.4× 236 0.7× 164 1.3× 47 0.5× 39 0.6× 38 1.4k
Susan Fanayan Australia 22 943 1.4× 177 0.5× 239 1.9× 195 2.0× 142 2.1× 27 1.2k

Countries citing papers authored by Eugene Goufman

Since Specialization
Citations

This map shows the geographic impact of Eugene Goufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Goufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Goufman more than expected).

Fields of papers citing papers by Eugene Goufman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Goufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Goufman. The network helps show where Eugene Goufman may publish in the future.

Co-authorship network of co-authors of Eugene Goufman

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Goufman. A scholar is included among the top collaborators of Eugene Goufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Goufman. Eugene Goufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Lokshin, Anna, Eugene Goufman, А. А. Степанов, et al.. (2021). Proteolyzed Variant of IgG with Free C-Terminal Lysine as a Biomarker of Prostate Cancer. Biology. 10(8). 817–817. 2 indexed citations
4.
Goufman, Eugene, et al.. (2018). Effect of Specific Cleavage of Immunoglobulin G by Plasmin on the Binding and Activation of Plasminogen. Russian Journal of Bioorganic Chemistry. 44(2). 210–216. 2 indexed citations
5.
Goufman, Eugene, et al.. (2015). Role of autoantibodies to plasminogen at oncologic diseases. Journal of Thrombosis and Haemostasis. 13. 304. 2 indexed citations
6.
Goufman, Eugene, et al.. (2015). Autoantibodies to Plasminogen and Their Role in Tumor Diseases. Bulletin of Experimental Biology and Medicine. 158(4). 493–496. 4 indexed citations
7.
Goufman, Eugene, Sergei A. Moshkovskii, Olga V. Tikhonova, et al.. (2006). Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions. Biochemistry (Moscow). 71(4). 354–360. 40 indexed citations
8.
Moshkovskii, Sergei A., Marina V. Serebryakova, Olga V. Tikhonova, et al.. (2005). Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. PROTEOMICS. 5(14). 3790–3797. 98 indexed citations
9.
Lokhov, Petr G., Olga V. Tikhonova, Sergei A. Moshkovskii, et al.. (2004). Database search post‐processing by neural network: Advanced facilities for identification of components in protein mixtures using mass spectrometric peptide mapping. PROTEOMICS. 4(3). 633–642. 16 indexed citations
10.
Govorun, Vadim M., Petr G. Lokhov, Sergei A. Moshkovskii, et al.. (2004). Comparative Analysis of Different Typing Methods for Helicobacter pylori Clinical Isolates. Biochemistry (Moscow). 69(5). 536–541. 3 indexed citations
11.
Govorun, Vadim M., Sergei A. Moshkovskii, Olga V. Tikhonova, et al.. (2003). Comparative Analysis of Proteome Maps of Helicobacter pylori Clinical Isolates. Biochemistry (Moscow). 68(1). 42–49. 53 indexed citations
12.
Gartel, Andrei L., Xin Ye, Eugene Goufman, et al.. (2001). Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proceedings of the National Academy of Sciences. 98(8). 4510–4515. 333 indexed citations
13.
Gartel, Andrei L., et al.. (2001). A Novel P53-Related Activity in a Colon Adenocarcinoma Cell Line With Mutant P53. The Scientific World JOURNAL. 1. 36–36. 1 indexed citations
14.
Gartel, Andrei L., Feridoon Najmabadi, Eugene Goufman, & Angela L. Tyner. (2000). A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription. Oncogene. 19(7). 961–964. 48 indexed citations
15.
Gartel, Andrei L., Eugene Goufman, Feridoon Najmabadi, & Angela L. Tyner. (2000). Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene. 19(45). 5182–5188. 68 indexed citations
16.
Gartel, Andrei L., Eugene Goufman, Sergei G. Tevosian, et al.. (1998). Activation and repression of p21WAF1/CIP1 transcription by RB binding proteins. Oncogene. 17(26). 3463–3469. 60 indexed citations
17.
Serfas, Michael S., Eugene Goufman, Miriam H. Feuerman, Andrei L. Gartel, & Angela L. Tyner. (1997). p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication.. PubMed. 8(9). 951–61. 33 indexed citations
18.
Gartel, Andrei L., Michael S. Serfas, Eugene Goufman, et al.. (1996). p21 (WAF1/CIP1) Expression Is Induced in Newly Nondividing Cells in Diverse Epithelia and during Differentiation of the Caco-2 Intestinal Cell Line. Experimental Cell Research. 227(2). 171–181. 109 indexed citations
19.
Резніков, А. Г., et al.. (1991). Metabolism of testosterone in discrete regions of the brain of rat embryos. Neuroscience and Behavioral Physiology. 21(3). 259–263.
20.
Goufman, Eugene, et al.. (1990). Experimental evidence for hypothalamic paraventricular nucleus involvement in the regulation of carbohydrate homeostasis.. PubMed. 1(2). 193–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026